| Cat. No. |
Product Name |
Information |
| PC-43412 |
Talabostat mesylate
DPP4 inhibitor
|
Talabostat (PT-100, Val-boroPro) is a potent, nonselective, orally available inhibitor of post-proline cleaving serine proteases with Ki of 0.18 nM for DPP4, also potently inhibits DPP8/9 (IC50=1.5/0.76 nM), FAP, DPP2 and some other DASH family enzymes. |
| PC-43097 |
DBPR108
DPP4 inhibitor
|
Prusogliptin (DBPR108) is a potent, selective, orally bioavailable and long-acting inhibitor of DPP4 with IC50 of 15 nM, >3,000-fold selectivity over DPP8, DPP9, FAP and DPP-II. |
| PC-63161 |
AZD-5248
DPP-1 inhibitor
|
AZD-5248 is a potent, selective, first generation, oral inhibitor of dipeptidyl peptidase 1 (DPP1). |
| PC-61445 |
Evogliptin
DPP-4 inhibitor
|
Evogliptin (DA1229) is a potent, long acting, reversible and competitive DPP-4 inhibitor with IC50 of 0.9 nM. |
| PC-60974 |
Gemigliptin
DPP-4 inhibitor
|
Gemigliptin (LC15-0444) is a potent, selective, competitive and orally active DPP4 inhibitor (IC50=10.4 nM, hDPP4) with potential for the treatment of type 2 diabetes. |
| PC-60517 |
Gosogliptin dihydrochloride
DPP-4 inhibitor
|
Gosogliptin dihydrochloride (PF-00734200) is a potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
| PC-60516 |
Gosogliptin
DPP-4 inhibitor
|
Gosogliptin (PF-734200, PF-00734200) is a potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
| PC-60515 |
Garvagliptin
DPP-4 inhibitor
|
Garvagliptin (NVP LAF 237A, LAF237A) is a potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment for type 2 diabetes. |
| PC-60064 |
Imigliptin dihydrochloride
DPP-4 inhibitor
|
Imigliptin dihydrochloride (KBP-3853) is a potent, selective, orally available DPP-4 inhibitor with IC50 of 9 nM. |
| PC-44866 |
Omarigliptin
DPP4 inhibitor
|
Omarigliptin (MK-3102) is a potent and selective DPP-4 inhibitor with IC50 of 1.4 nM. |
| PC-42508 |
Linagliptin
DPP4 inhibitor
|
Linagliptin (BI-1356) is a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor with IC50 of 1 nM. |
| PC-42510 |
Saxagliptin hydrate
DPP4 inhibitor
|
Saxagliptin (BMS-477118) hydrate is a highly potent, long-acting, orally active DPP4 inhibitor with Ki of 0.6 nM. |
